黒人女性の冠動脈疾患の生存率は,黒人の男性と比較して黒人の女性でした
Y Liao1, R S Cooper, J K Ghali
1Department of Preventive Medicine and Epidemiology, Loyola University Medical Center, Maywood, IL 60153.
JAMA
|October 14, 1992
まとめ
冠動脈疾患の黒人女性は,黒人男性と同様の生存率を持っています. しかし,女性は,この病気のない男性と比較して,より悪い予後と向き合っています.
科学分野:
- 心臓病学 心臓病学
- 公衆衛生は公衆衛生である.
- 健康の格差について
背景:
- 冠動脈性心疾患 (CHD) は,さまざまな集団に影響し,結果の潜在的格差があります.
- CHDの黒人患者のジェンダー特異的な予後を理解することは,ターゲットを絞った介入に不可欠です.
研究 の 目的:
- 特に黒人患者集団における冠動脈疾患 (CHD) の予後に対するジェンダーの影響を調査する.
主な方法:
- イリノイ州シカゴの病院のレジストリから連続したサンプルを用いてコホート研究が行われました.
- 1719人の黒人患者 (780人の男性,939人の女性) が加熱手術,急性心筋梗塞の入院,冠動脈バイパス移植を受けた.
- フォローアップ期間は平均4年,様々なリスク要因に対する調整された分析が行われました.
主要な成果:
- 急性心筋梗塞と冠動脈バイパス移植の全体的な死亡率は,男性と女性の間で類似していました.
- 心臓発作による死亡の相対的なリスクは,調整後のCHD,心筋梗塞,またはバイパス移植において,女性と男性の間で有意な違いを示さなかった.
- しかし,心臓病のない同性の人と比較して,女性は男性よりも有害な結果に対する相対リスクの見積もりが大幅に高かった.
結論:
- 冠動脈性心疾患の黒人女性の予後は,黒人男性の予後と同等である.
- CHDの黒人女性は,男性と比較して,この病気のない同性の人と比較して,かなり悪い予後をします.
関連する概念動画
X-linked Traits
In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.
Disorders of the Male Reproductive System
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...


